Skip to main content

Diametric Capital, LP

SEC CIK
0001719087
Latest filing
Aug 14, 2026

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by Diametric Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings

Shares (Q2 2026)
959
Value
$514.9K
% of portfolio
0.1%
Quarters held
1
Since Q2 2026
Holdings of MDGL by Diametric Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026959$514.9K0.1%+959NewHolders